Vita Life Sciences Limited reported earnings results for the year ended December 31, 2012. For the year, the company's revenue was $30.191 million compared with $24.267 million a year ago. EBIT was $2.865 million compared with $1.489 million a year ago. Profit before tax was $2.841 million compared with $1.403 million a year ago. Profit after tax was $2.316 million or 4.14 cents per share compared with $1.213 million or 2.12 cents per share a year ago. EBITDA was $2.87 million compared with $1.49 million a year ago. Operating cash flows were $1.38 million compared with $5.66 million a year ago. The company declared final dividend of 0.5 cent per share for the year ended December 31, 2012. Total dividend for the financial year was 1.0 cent per share. The dividend will be payable on March 28, 2013 to the shareholders of record on March 15, 2013. The ex-dividend date is March 8, 2013. Barring unforeseen circumstances, the company is targeting a 40% to 50% increase in EBIT in the fiscal year 2013.

Vita Life Sciences Limited announced that they will report fiscal year 2012 results on Feb 28, 2013

Vita Life Sciences Limited provided group earnings guidance for the second half and full year ending December 2012. For the period, the group expects revenue to continue its momentum with growth in the second half of the year being similar to the first half. NPAT for the second half is anticipated to be similar to the first half. Based on the group's management accounts to October and its forecast for November and December 2012: Sales revenue is forecast to be $29.0 million to $30.0 million, or approximately 20% higher than the year to December 31, 2011. Profit before tax to be approximately 18% - 20% higher than that reported for the six months to June 2012. For the year, the company expects profit before tax to be approximately $2.3 million, or 65% higher than the year to December 2011. The company’s Directors expect to declare a fully franked final dividend of 0.5 cent per share payable in April 2013.